ZA97847B - Selective taxanes, a process for the preparation thereof and the use thereof as medicaments. - Google Patents
Selective taxanes, a process for the preparation thereof and the use thereof as medicaments.Info
- Publication number
- ZA97847B ZA97847B ZA9700847A ZA97847A ZA97847B ZA 97847 B ZA97847 B ZA 97847B ZA 9700847 A ZA9700847 A ZA 9700847A ZA 97847 A ZA97847 A ZA 97847A ZA 97847 B ZA97847 B ZA 97847B
- Authority
- ZA
- South Africa
- Prior art keywords
- microtubules
- pct
- taxol
- depolymerisation
- mitosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19605024A DE19605024A1 (de) | 1996-01-31 | 1996-01-31 | Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA97847B true ZA97847B (en) | 1997-08-04 |
Family
ID=7785142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9700847A ZA97847B (en) | 1996-01-31 | 1997-01-31 | Selective taxanes, a process for the preparation thereof and the use thereof as medicaments. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6162920A (pl) |
| EP (1) | EP0896577B1 (pl) |
| JP (1) | JP2001505527A (pl) |
| KR (1) | KR19990082151A (pl) |
| CN (1) | CN1073108C (pl) |
| AT (1) | ATE233757T1 (pl) |
| AU (1) | AU714313B2 (pl) |
| BR (1) | BR9708295A (pl) |
| CA (1) | CA2244746A1 (pl) |
| CZ (1) | CZ292504B6 (pl) |
| DE (2) | DE19605024A1 (pl) |
| DK (1) | DK0896577T3 (pl) |
| ES (1) | ES2192261T3 (pl) |
| HK (1) | HK1018778A1 (pl) |
| HU (1) | HUP9901027A3 (pl) |
| IL (1) | IL124951A (pl) |
| NO (1) | NO983509L (pl) |
| PL (1) | PL186796B1 (pl) |
| PT (1) | PT896577E (pl) |
| RU (1) | RU2163599C2 (pl) |
| SK (1) | SK101198A3 (pl) |
| TR (1) | TR199801415T2 (pl) |
| TW (1) | TW444015B (pl) |
| UA (1) | UA49007C2 (pl) |
| WO (1) | WO1997028156A1 (pl) |
| ZA (1) | ZA97847B (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002070512A1 (fr) | 2001-03-07 | 2002-09-12 | Daiichi Pharmaceutical Co, Ltd. | Procede de fabrication d'un derive d'azetidinone-2 |
| WO2004078065A2 (en) | 2003-03-03 | 2004-09-16 | Sinus Rhythm Technologies, Inc. | Electrical conduction block implant device |
| CN1296391C (zh) * | 2004-03-04 | 2007-01-24 | 中国人民解放军第二军医大学 | 氟代羧烷基环糊精醚类化合物及其制备方法和应用 |
| DK1746976T3 (en) | 2004-05-03 | 2017-04-10 | Merrimack Pharmaceuticals Inc | LIPOSOMES SUITABLE FOR PHARMACEUTICAL SUPPLY |
| US8658203B2 (en) | 2004-05-03 | 2014-02-25 | Merrimack Pharmaceuticals, Inc. | Liposomes useful for drug delivery to the brain |
| US9717724B2 (en) | 2012-06-13 | 2017-08-01 | Ipsen Biopharm Ltd. | Methods for treating pancreatic cancer using combination therapies |
| AU2013202947B2 (en) | 2012-06-13 | 2016-06-02 | Ipsen Biopharm Ltd. | Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan |
| US11318131B2 (en) | 2015-05-18 | 2022-05-03 | Ipsen Biopharm Ltd. | Nanoliposomal irinotecan for use in treating small cell lung cancer |
| PT3337467T (pt) | 2015-08-20 | 2021-01-25 | Ipsen Biopharm Ltd | Terapia de combinação utilizando irinotecano lipossomal e um inibidor parp para tratamento do cancro |
| WO2017034957A1 (en) | 2015-08-21 | 2017-03-02 | Merrimack Pharmaceuticals, Inc. | Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin |
| AU2016340153B2 (en) | 2015-10-16 | 2022-06-02 | Ipsen Biopharm Ltd. | Stabilizing camptothecin pharmaceutical compositions |
| WO2018083470A1 (en) | 2016-11-02 | 2018-05-11 | Ipsen Biopharm Ltd. | Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluoruracil (and leucovorin) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5489601A (en) * | 1991-09-23 | 1996-02-06 | Florida State University | Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them |
| US5227400A (en) * | 1991-09-23 | 1993-07-13 | Florida State University | Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them |
| PT690712E (pt) * | 1993-03-22 | 2002-05-31 | Univ Florida State | Taxanos possuindo uma cadeia lateral substituida com piridilo |
| US5415869A (en) * | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
| FR2715307B1 (fr) * | 1994-01-25 | 1996-04-05 | Commissariat Energie Atomique | Procédé de solubilisation dans un milieu aqueux d'agents antitumoraux de la famille du taxol, et cyclodextrines ramifiées utilisables pour cette solubilisation. |
| DE69504843T2 (de) * | 1994-06-28 | 1999-02-11 | Upjohn Co | 7-äther-taxol ähnliche verbindungen antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen |
-
1996
- 1996-01-31 DE DE19605024A patent/DE19605024A1/de not_active Withdrawn
-
1997
- 1997-01-31 CZ CZ19982426A patent/CZ292504B6/cs not_active IP Right Cessation
- 1997-01-31 WO PCT/EP1997/000440 patent/WO1997028156A1/en not_active Application Discontinuation
- 1997-01-31 RU RU98116122/04A patent/RU2163599C2/ru not_active IP Right Cessation
- 1997-01-31 IL IL12495197A patent/IL124951A/xx not_active IP Right Cessation
- 1997-01-31 US US09/117,506 patent/US6162920A/en not_active Expired - Fee Related
- 1997-01-31 PT PT97902286T patent/PT896577E/pt unknown
- 1997-01-31 CA CA002244746A patent/CA2244746A1/en not_active Abandoned
- 1997-01-31 ZA ZA9700847A patent/ZA97847B/xx unknown
- 1997-01-31 TR TR1998/01415T patent/TR199801415T2/xx unknown
- 1997-01-31 SK SK1011-98A patent/SK101198A3/sk unknown
- 1997-01-31 DK DK97902286T patent/DK0896577T3/da active
- 1997-01-31 UA UA98084638A patent/UA49007C2/uk unknown
- 1997-01-31 JP JP52730897A patent/JP2001505527A/ja active Pending
- 1997-01-31 HU HU9901027A patent/HUP9901027A3/hu unknown
- 1997-01-31 CN CN97192006A patent/CN1073108C/zh not_active Expired - Fee Related
- 1997-01-31 KR KR1019980705874A patent/KR19990082151A/ko not_active Application Discontinuation
- 1997-01-31 DE DE69719502T patent/DE69719502T2/de not_active Expired - Lifetime
- 1997-01-31 BR BR9708295A patent/BR9708295A/pt not_active Application Discontinuation
- 1997-01-31 TW TW086101169A patent/TW444015B/zh active
- 1997-01-31 AT AT97902286T patent/ATE233757T1/de not_active IP Right Cessation
- 1997-01-31 AU AU15984/97A patent/AU714313B2/en not_active Ceased
- 1997-01-31 ES ES97902286T patent/ES2192261T3/es not_active Expired - Lifetime
- 1997-01-31 PL PL97328055A patent/PL186796B1/pl not_active IP Right Cessation
- 1997-01-31 EP EP97902286A patent/EP0896577B1/en not_active Expired - Lifetime
-
1998
- 1998-07-30 NO NO983509A patent/NO983509L/no unknown
-
1999
- 1999-09-02 HK HK99103795A patent/HK1018778A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA97847B (en) | Selective taxanes, a process for the preparation thereof and the use thereof as medicaments. | |
| Yue et al. | Microtubule-binding natural products for cancer therapy | |
| Dumontet et al. | Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death | |
| RU2213097C2 (ru) | Гетероциклы в качестве ингибиторов адгезии лейкоцитов и vla-4-антагонистов | |
| AU3968589A (en) | Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles | |
| ATE229018T1 (de) | Antitumorverbindungen, pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung und behandlungsmethoden | |
| FI935821A0 (fi) | Fosfonooximetylestrar av taxanderivat | |
| MA26674A1 (fr) | Derives d'hydroxamides heterocycliques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| EA012625B1 (ru) | Цитотоксические агенты, содержащие новые таксаны | |
| ES2168304T3 (es) | Derivados del taxol. | |
| US7196115B2 (en) | Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings, method therefor | |
| US5547981A (en) | Taxol-7-carbazates | |
| ATE202551T1 (de) | Lignane, verfahren zu ihrer herstellung, ihre pharmazeutische compositionen und anwendungen | |
| Nitika et al. | Microtubule targeting agents: a benchmark in cancer therapy | |
| DZ3046A1 (fr) | Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| EP0531419A4 (en) | Bistriazenes as chemotherapeutic agents | |
| TW364905B (en) | Lactone compound and process of production thereof | |
| von Angerer | New inhibitors of tubulin polymerisation | |
| DE69430797D1 (de) | C9 taxanderivate und diese enthaltende pharmazeutische zusammensetzungen | |
| TNSN00114A1 (fr) | Hydroxamides d'acide 3-(arylsulfonylamino)-tetrahydrofuranne-3- carboxyliques, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| Sampath et al. | Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel-and docetaxel-resistant tumor models | |
| Nishio et al. | Cytoskeletons and antimitotic agents developed in Japan | |
| Haar | Taxanes and other microtubule stabilising agents | |
| Roller et al. | CIRCUMVENTION OF MULTIDRUG RESISTANCE BY ADDITION OF CALCIUMI CALMODULIN ANTAGONISTS TO CYTOSTATIC DRUGS | |
| EP1572191A1 (en) | Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings |